Skip to main content

Articles

Page 47 of 65

  1. Although integrins have been implicated in the progression of breast cancer, the exact mechanism whereby they exert this regulation is clearly not understood. To understand the role of integrins in breast canc...

    Authors: Yanfang Wang, Sylvia Shenouda, Somesh Baranwal, Rajamani Rathinam, Prachi Jain, Lili Bao, Siddhartha Hazari, Srikanta Dash and Suresh K Alahari
    Citation: Molecular Cancer 2011 10:84
  2. RecQ helicases play an essential role in the maintenance of genome stability. In humans, loss of RecQ helicase function is linked with predisposition to cancer and/or premature ageing. Current data show that t...

    Authors: Ramiro Mendoza-Maldonado, Valentina Faoro, Sailesh Bajpai, Matteo Berti, Federico Odreman, Marco Vindigni, Tamara Ius, Abdollah Ghasemian, Serena Bonin, Miran Skrap, Giorgio Stanta and Alessandro Vindigni
    Citation: Molecular Cancer 2011 10:83
  3. Overexpression of the RON receptor tyrosine kinase contributes to epithelial cell transformation, malignant progression, and acquired drug resistance. RON also has been considered as a potential target for the...

    Authors: Hang-Ping Yao, Yong-Qing Zhou, Qi Ma, Sunny Guin, Snehal S Padhye, Rui-Wen Zhang and Ming-Hai Wang
    Citation: Molecular Cancer 2011 10:82
  4. The MFSD2A gene maps within a linkage disequilibrium block containing the MYCL1-EcoRI polymorphism associated with prognosis and survival in lung cancer patients. Survival discrepancies between Asians and Caucasi...

    Authors: Francesca Colombo, Felicia S Falvella, Antonella Galvan, Elisa Frullanti, Hideo Kunitoh, Toshikazu Ushijima and Tommaso A Dragani
    Citation: Molecular Cancer 2011 10:81
  5. Resistance to chemotherapy remains one of the principle obstacles to the treatment of colon cancer. In order to identify the molecular mechanism of this resistance, we investigated the role of the steroid and ...

    Authors: Agnes Basseville, Laurence Preisser, Sophie de Carné Trécesson, Michèle Boisdron-Celle, Erick Gamelin, Olivier Coqueret and Alain Morel
    Citation: Molecular Cancer 2011 10:80
  6. Rho-associated coiled-coil containing protein kinase (Rho-kinase/ROCK) is involved in various cellular functions including cell proliferation, and is generally considered to be oncogenic, while some studies sh...

    Authors: Masanori Nakashima, Seiji Adachi, Ichiro Yasuda, Takahiro Yamauchi, Junji Kawaguchi, Toshimasa Hanamatsu, Takashi Yoshioka, Yukio Okano, Yoshinobu Hirose, Osamu Kozawa and Hisataka Moriwaki
    Citation: Molecular Cancer 2011 10:79
  7. The aim of both classical (e.g. taxol) and targeted anti-mitotic agents (e.g. Aurora kinase inhibitors) is to disrupt the mitotic spindle. Such compounds are currently used in the clinic and/or are being teste...

    Authors: Sanket Joshi, Antony W Braithwaite, Phillip J Robinson and Megan Chircop
    Citation: Molecular Cancer 2011 10:78
  8. The aim of this study was to determine whether low prevalence human papillomavirus (HPV) 16 E6 variants differ from high prevalence types in their functional abilities. We evaluated functions relevant to carci...

    Authors: Ingeborg Zehbe, Hava Lichtig, Ashley Westerback, Paul F Lambert, Massimo Tommasino and Levana Sherman
    Citation: Molecular Cancer 2011 10:77
  9. Worldwide, lung cancer kills more people than breast, colon and prostate cancer combined. Alterations in macrophage number and function during lung tumorigenesis suggest that these immune effector cells stimul...

    Authors: Jason M Fritz, Lori D Dwyer-Nield and Alvin M Malkinson
    Citation: Molecular Cancer 2011 10:76
  10. Platinum-containing chemotherapy produces specific DNA damage and is used to treat several human solid tumors. Tumors initially sensitive to platinum-based drugs frequently become resistant. Inhibition of DNA ...

    Authors: Janna Sand-Dejmek, Guillaume Adelmant, Bijan Sobhian, Anne S Calkins, Jarrod Marto, Dirk J Iglehart and Jean-Bernard Lazaro
    Citation: Molecular Cancer 2011 10:74
  11. Migration of metastatic tumor cells from the bloodstream into lymph nodes is thought to be facilitated by expression of the chemokine receptors CCR7, CXCR4 and, for B cell-derived tumors, CXCR5. Expression of ...

    Authors: Brian A Zabel, Susanna Lewén, Robert D Berahovich, Juan C Jaén and Thomas J Schall
    Citation: Molecular Cancer 2011 10:73
  12. Cyclin-dependent kinases 2, 4 and 6 (Cdk2, Cdk4, Cdk6) are closely structurally homologous proteins which are classically understood to control the transition from the G1 to the S-phases of the cell cycle by c...

    Authors: Hilmar M Warenius, Jeremy D Kilburn, Jon W Essex, Richard I Maurer, Jeremy P Blaydes, Usha Agarwala and Laurence A Seabra
    Citation: Molecular Cancer 2011 10:72
  13. High-risk human papillomavirus (hrHPV) infections are causally related to cervical cancer development. The additional (epi)genetic alterations driving malignant transformation of hrHPV-infected cells however, ...

    Authors: Florianne E Henken, N Sanjib Banerjee, Peter JF Snijders, Chris JLM Meijer, Johanna De-Castro Arce, Frank Rösl, Thomas R Broker, Louise T Chow and Renske DM Steenbergen
    Citation: Molecular Cancer 2011 10:71
  14. Methuosis is a unique form of non-apoptotic cell death triggered by alterations in the trafficking of clathrin-independent endosomes, ultimately leading to extreme vacuolization and rupture of the cell.

    Authors: Jean H Overmeyer, Ashley M Young, Haymanti Bhanot and William A Maltese
    Citation: Molecular Cancer 2011 10:69
  15. Histone deacetylase (HDAC) inhibitors are currently undergoing clinical evaluation as anti-cancer agents. Dietary constituents share certain properties of HDAC inhibitor drugs, including the ability to induce ...

    Authors: Praveen Rajendran, Barbara Delage, W Mohaiza Dashwood, Tian-Wei Yu, Bradyn Wuth, David E Williams, Emily Ho and Roderick H Dashwood
    Citation: Molecular Cancer 2011 10:68
  16. Progression of pancreatic ductal adenocarcinoma (PDAC) is largely the result of genetic and/or epigenetic alterations in the transforming growth factor-beta (TGF-β)/Smad signalling pathway, eventually resultin...

    Authors: Hendrik Ungefroren, Stephanie Groth, Susanne Sebens, Hendrik Lehnert, Frank Gieseler and Fred Fändrich
    Citation: Molecular Cancer 2011 10:67
  17. Epithelial to mesenchymal transition (EMT) occurs during cancer cell invasion and malignant metastasis. Features of EMT include spindle-like cell morphology, loss of epithelial cellular markers and gain of mes...

    Authors: Qi Ma, Sunny Guin, Snehal S Padhye, Yong-Qing Zhou, Rui-Wen Zhang and Ming-Hai Wang
    Citation: Molecular Cancer 2011 10:66
  18. The research emphasis in anti-cancer drug discovery has always been to search for a drug with the greatest antitumor potential but fewest side effects. This can only be achieved if the drug used is against a s...

    Authors: Gouji Toyokawa, Ken Masuda, Yataro Daigo, Hyun-Soo Cho, Masanori Yoshimatsu, Masashi Takawa, Shinya Hayami, Kazuhiro Maejima, Makoto Chino, Helen I Field, David E Neal, Eiju Tsuchiya, Bruce AJ Ponder, Yoshihiko Maehara, Yusuke Nakamura and Ryuji Hamamoto
    Citation: Molecular Cancer 2011 10:65
  19. Topoisomerase I (TOP1) is a nuclear enzyme that catalyzes the relaxation of supercoiled DNA during DNA replication and transcription. TOP1 is the molecular target of camptothecin and related drugs such as irin...

    Authors: Céline Gongora, Nadia Vezzio-Vie, Sandie Tuduri, Vincent Denis, Annick Causse, Céline Auzanneau, Gwenaëlle Collod-Beroud, Arnaud Coquelle, Philippe Pasero, Philippe Pourquier, Pierre Martineau and Maguy Del Rio
    Citation: Molecular Cancer 2011 10:64
  20. Homeobox genes murine Rhox5 and human RHOXF1 are expressed in early embryonic stages and then mostly restricted to germline tissues in normal adult, yet they are aberrantly expressed in cancer cells in vitro and

    Authors: Qiang Li, Mark E O'Malley, David L Bartlett and Sheng Guo
    Citation: Molecular Cancer 2011 10:63
  21. BRCA1 has recently been identified as a potential regulator of mammary stem/progenitor cell differentiation, and this function may explain the high prevalence of breast cancer in BRCA1 mutation carriers, as well ...

    Authors: Crista Thompson, Gwen MacDonald and Christopher R Mueller
    Citation: Molecular Cancer 2011 10:62
  22. Infection with high-risk human papillomaviruses (HPVs) such as HPV-16 is intimately associated with squamous cell carcinomas (SCCs) of the anogenital tract and a subset of oropharyngeal carcinomas. Such lesion...

    Authors: Nina Korzeniewski, Benjamin Treat and Stefan Duensing
    Citation: Molecular Cancer 2011 10:61
  23. HOX genes encode a family of homeodomain-containing transcription factors involved in the determination of cell fate and identity during embryonic development. They also behave as oncogenes in some malignancies.

    Authors: Masanao Tabuse, Shigeki Ohta, Yohei Ohashi, Raita Fukaya, Aya Misawa, Kazunari Yoshida, Takeshi Kawase, Hideyuki Saya, Cécile Thirant, Hérve Chneiweiss, Yumi Matsuzaki, Hideyuki Okano, Yutaka Kawakami and Masahiro Toda
    Citation: Molecular Cancer 2011 10:60
  24. Astrocytomas are the most common and aggressive brain tumors characterized by their highly invasive growth. Gain of chromosome 7 with a hot spot at 7q32 appears to be the most prominent aberration in astrocyto...

    Authors: Minfeng Shu, Xiaoke Zheng, Sihan Wu, Huimin Lu, Tiandong Leng, Wenbo Zhu, Yuehan Zhou, Yanqiu Ou, Xi Lin, Yuan Lin, Dong Xu, Yuxi Zhou and Guangmei Yan
    Citation: Molecular Cancer 2011 10:59
  25. There is evidence from epidemiological and in vitro studies that the biological effects of testosterone (T) on cell cycle and survival are modulated by 1,25-dihydroxyvitamin D3 (1,25(OH)2D3) in prostate cancer. T...

    Authors: Wei-Lin W Wang, Namita Chatterjee, Sridar V Chittur, JoEllen Welsh and Martin P Tenniswood
    Citation: Molecular Cancer 2011 10:58
  26. The receptor for the cardiac hormone atrial natriuretic peptide (ANP), natriuretic peptide receptor A (NPRA), is expressed in cancer cells, and natriuretic peptides have been implicated in cancers. However, th...

    Authors: Xiaoqin Wang, Payal Raulji, Shyam S Mohapatra, Ronil Patel, Gary Hellermann, Xiaoyuan Kong, Pedro L Vera, Katherine L Meyer-Siegler, Domenico Coppola and Subhra Mohapatra
    Citation: Molecular Cancer 2011 10:56
  27. microRNAs (miRNAs) are small non-coding RNAs that are frequently involved in carcinogenesis. Although many miRNAs form part of integrated networks, little information is available how they interact with each o...

    Authors: Nora Bandi and Erik Vassella
    Citation: Molecular Cancer 2011 10:55
  28. Current large-scale cancer sequencing projects have identified large numbers of somatic mutations covering an increasing number of different cancer tissues and patients. However, the characterization of these ...

    Authors: Henning Stehr, Seon-Hi J Jang, José M Duarte, Christoph Wierling, Hans Lehrach, Michael Lappe and Bodo MH Lange
    Citation: Molecular Cancer 2011 10:54
  29. We compared microRNA expression patterns in three cisplatin resistant sublines derived from paternal cisplatin sensitive germ cell tumor cell lines in order to improve our understanding of the mechanisms of ci...

    Authors: Matthias Port, Stephanie Glaesener, Christian Ruf, Armin Riecke, Carsten Bokemeyer, Viktor Meineke, Friedemann Honecker and Michael Abend
    Citation: Molecular Cancer 2011 10:52
  30. The acquisition of proliferative and invasive phenotypes is considered a hallmark of neoplastic transformation; however, the underlying mechanisms are less well known. Lipid phosphate phosphatase-3 (LPP3) not ...

    Authors: Ishita Chatterjee, Joseph O Humtsoe, Erin E Kohler, Claudio Sorio and Kishore K Wary
    Citation: Molecular Cancer 2011 10:51
  31. The pre-leukemia transcription factor 3 (PBX) is part of the PBX family of transcription factors, which is known to regulate genes involved in differentiation of urogenital organs and steroidogenesis. This is ...

    Authors: Håkon Ramberg, Ayham Alshbib, Viktor Berge, Aud Svindland and Kristin Austlid Taskén
    Citation: Molecular Cancer 2011 10:50
  32. Hormone therapy is the standard of care for newly diagnosed or recurrent prostate cancers. It uses anti-androgen agents, castration, or both to eliminate cancer promoting effect of testicular androgen. The p53...

    Authors: Christian Tovar, Brian Higgins, Kenneth Kolinsky, Mingxuan Xia, Kathryn Packman, David C Heimbrook and Lyubomir T Vassilev
    Citation: Molecular Cancer 2011 10:49
  33. Undifferentiated nasopharyngeal carcinoma (NPC) is strongly related to Epstein-Barr virus (EBV) infection, allowing aberrant antibodies against EBV and viral DNA load as screening tools in high risk population...

    Authors: Susanna H Hutajulu, Sagung R Indrasari, Luh PL Indrawati, Ahmad Harijadi, Sylvia Duin, Sofia M Haryana, Renske DM Steenbergen, Astrid E Greijer and Jaap M Middeldorp
    Citation: Molecular Cancer 2011 10:48
  34. Tumor recurrence and metastasis develop as a result of tumors' acquisition of anti-apoptotic mechanisms and therefore, it is necessary to develop novel effective therapeutics against metastatic cancers. In thi...

    Authors: Hak-Bong Kim, Mi-Ju Kim, Dae-Young Kim, Jae-Won Lee, Jae-Ho Bae, Dong-Wan Kim, Chi-Dug Kang and Sun-Hee Kim
    Citation: Molecular Cancer 2011 10:46
  35. With cAMP signaling having a profound inhibitory effect on DNA damage-induced apoptosis in B-cell precursor acute lymphoblastic leukemia (BCP-ALL) cells, understanding how this signaling pathway affects the su...

    Authors: Martine M Kloster, Elin H Naderi, Harald Carlsen, Heidi K Blomhoff and Soheil Naderi
    Citation: Molecular Cancer 2011 10:45
  36. Glycochenodeoxycholate (GCDA) is one of the major human bile salts. Bile salts stimulate cell survival and proliferation through the mitogen-activated protein kinase, but the downstream signaling mechanism(s) ...

    Authors: Mingmei Liao, Jinfeng Zhao, Ton Wang, Jinghua Duan, Yangde Zhang and Xingming Deng
    Citation: Molecular Cancer 2011 10:44
  37. Oxidative stress has been implicated in the pathogenesis of a wide spectrum of human diseases, including Hepatitis B virus (HBV)-related liver disease. Hepatitis B virus X protein (HBx) is a key regulator of H...

    Authors: Liang Hu, Lei Chen, GuangZhen Yang, Liang Li, HanYong Sun, YanXin Chang, QianQian Tu, MengChao Wu and HongYang Wang
    Citation: Molecular Cancer 2011 10:43
  38. The increasing availability of different monoclonal antibodies (mAbs) opens the way to more specific biologic therapy of cancer patients. However, despite the significant success of therapy in breast and ovari...

    Authors: Séverine Loisel, Pierre-Alain André, Josee Golay, Franz Buchegger, Jean Kadouche, Martine Cérutti, Luca Bologna, Marek Kosinski, David Viertl, Angelika Bischof Delaloye, Christian Berthou, Jean-Pierre Mach and Laurence Boumsell
    Citation: Molecular Cancer 2011 10:42
  39. MicroRNAs are important regulators of transcription in hematopoiesis. Their expression deregulations were described in association with pathogenesis of some hematological malignancies. This study provides inte...

    Authors: Kateřina Machová Poláková, Tereza Lopotová, Hana Klamová, Pavel Burda, Marek Trněný, Tomáš Stopka and Jana Moravcová
    Citation: Molecular Cancer 2011 10:41
  40. Polycomb repressive complex 2 (PRC2) mediates gene silencing through histone H3K27 methylation. PRC2 components are over-expressed in metastatic prostate cancer (PC), and are required for cancer stem cell (CSC...

    Authors: Francesco Crea, Elaine M Hurt, Lesley A Mathews, Stephanie M Cabarcas, Lei Sun, Victor E Marquez, Romano Danesi and William L Farrar
    Citation: Molecular Cancer 2011 10:40
  41. Specific types of high risk Human papillomaviruses (HR-HPVs) particularly, HPV types 16 and 18 cause cervical cancer and while the two recently developed vaccines against these HPV types are prophylactic in na...

    Authors: Sutapa Mahata, Alok C Bharti, Shirish Shukla, Abhishek Tyagi, Syed A Husain and Bhudev C Das
    Citation: Molecular Cancer 2011 10:39
  42. Long non-coding RNAs (lncRNAs) are emerging as new players in the cancer paradigm demonstrating potential roles in both oncogenic and tumor suppressive pathways. These novel genes are frequently aberrantly exp...

    Authors: Ewan A Gibb, Carolyn J Brown and Wan L Lam
    Citation: Molecular Cancer 2011 10:38
  43. Nrf2 is a key transcriptional regulator of a battery of genes that facilitate phase II/III drug metabolism and defence against oxidative stress. Nrf2 is largely regulated by Keap1, which directs Nrf2 for prote...

    Authors: Adam Lister, Taoufik Nedjadi, Neil R Kitteringham, Fiona Campbell, Eithne Costello, Bryony Lloyd, Ian M Copple, Samantha Williams, Andrew Owen, John P Neoptolemos, Chris E Goldring and B Kevin Park
    Citation: Molecular Cancer 2011 10:37
  44. Most bladder cancer patients experience lymphatic metastasis in the course of disease progression, yet the relationship between lymphangiogenesis and lymphatic metastasis is not well known. The aim of this stu...

    Authors: Hanseul Yang, Chan Kim, Min-Ju Kim, Reto A Schwendener, Kari Alitalo, Warren Heston, Injune Kim, Wun-Jae Kim and Gou Young Koh
    Citation: Molecular Cancer 2011 10:36
  45. Survivin (BIRC5), a member of the inhibitor of apoptosis protein (IAP) family that inhibits caspases and blocks cell death is highly expressed in cancer and is associated with a poorer clinical outcome. Functioni...

    Authors: Ronan J Kelly, Ariel Lopez-Chavez, Deborah Citrin, John E Janik and John C Morris
    Citation: Molecular Cancer 2011 10:35

Annual Journal Metrics

  • 2022 Citation Impact
    37.3 - 2-year Impact Factor
    33.1 - 5-year Impact Factor
    5.740 - SNIP (Source Normalized Impact per Paper)
    8.703 - SJR (SCImago Journal Rank)

    2023 Speed
    5 days submission to first editorial decision for all manuscripts (Median)
    91 days submission to accept (Median)

    2023 Usage 
    3,569,666 downloads
    2,070 Altmetric mentions